Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 10, 2023 - Issue
Submit an article Journal homepage
221
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients

Francesca Benevento1 Department of Medicine and Surgical Sciences (DIMEC), University of Bologna, Bologna, ItalyView further author information
,
Anna Pecorelli2 Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyView further author information
,
Horia Stefanescu3 Gastroenterology Department, Liver Unit & Ultrasound Laboratory, Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, RomaniaORCID Iconhttps://orcid.org/0000-0002-4034-5471View further author information
ORCID Icon,
Zeno Sparchez3 Gastroenterology Department, Liver Unit & Ultrasound Laboratory, Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, RomaniaView further author information
,
Ranka Vukotic1 Department of Medicine and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy;4 Medicina Interna 4, Azienda Ospedaliero-Universitaria Pisana, Pisa, ItalyView further author information
,
Irene Pettinari2 Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyView further author information
,
Crina-Anca Grigoras3 Gastroenterology Department, Liver Unit & Ultrasound Laboratory, Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, RomaniaView further author information
,
Francesco Tovoli1 Department of Medicine and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy;5 Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyView further author information
,
Federico Ravaioli1 Department of Medicine and Surgical Sciences (DIMEC), University of Bologna, Bologna, ItalyORCID Iconhttps://orcid.org/0000-0002-1142-8585View further author information
ORCID Icon,
Bernardo Stefanini1 Department of Medicine and Surgical Sciences (DIMEC), University of Bologna, Bologna, ItalyORCID Iconhttps://orcid.org/0000-0003-3800-5678View further author information
ORCID Icon,
Pietro Andreone6 Divisione di Medicina Interna a Indirizzo Metabolico-Nutrizionale, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyORCID Iconhttps://orcid.org/0000-0002-4794-9809View further author information
ORCID Icon &
Fabio Piscaglia1 Department of Medicine and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy;5 Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8264-1845View further author information
ORCID Icon show all
Pages 473-482 | Received 27 Oct 2022, Accepted 15 Mar 2023, Published online: 27 Mar 2023

References

  • Andriulli A, Tripodi A, Angeli P.; Under the Auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI). Hemostatic balance in patients with liver cirrhosis: report of a consensus conference. Dig Liver Dis. 2016;48(5):455–467. doi:10.1016/j.dld.2016.02.008
  • Tsochatzis EA, Senzolo M, Germani G, et al. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther. 2010;31(3):366–374. doi:10.1111/j.1365-2036.2009.04182.x
  • Violi F, Corazza RG, Caldwell SH, et al. Portalvein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry. Intern Emerg Med. 2016;11:1059–1066. doi:10.1007/s11739-016-1416-8
  • von Kockritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep. 2017;5(2):148–156. doi:10.1093/gastro/gox014
  • Mahé I, Chidiac J, Bertoletti L, et al.; RIETE investigators. The clinical course of venousthromboembolism may differ to cancer site. Am J Med. 2017;130(3):337–347. doi:10.1016/j.amjmed.2016.10.017
  • Prins MH, Lensing AWA, Brighton TA, et al. Oral rivaroxaban versus enoxaparin with vitamin Kantagonist for the treatment of symptomatic venousthromboembolism in patients with cancer (EINSTEIN-DVTand EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials. Lancet Haematol. 2014;1(1):e37–e46. doi:10.1016/S2352-3026(14)70018-3
  • Nery F, Chevret S, Condat B, et al. Causes and consequences of portal vein thrombosis in 1243 patients with cirrhosis: results of a longitudinal study. Hepatology. 2015;61:660–667. doi:10.1002/hep.27546
  • Villa E, Cammà C, Marietta M, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. 2012;143:1253–1260. doi:10.1053/j.gastro.2012.07.018
  • Pettinari I, Vukotic R, Stefanescu H, et al.; BO-LIVES (Bologna LIVErvascular Studies). Clinical impact and safety of anticoagulants for portal vein thrombosis in chirrhosis. Am J Gastroenterol. 2019;114(2):258–266. doi:10.1038/s41395-018-0421-0
  • Piscaglia F, Gianstefani A, Ravaioli M, et al. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Transpl. 2010;16:658–667. doi:10.1002/lt.22044
  • Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3(1):27–34. PMID: 11908507. doi:10.1016/s1470-2045(01)00619-2
  • Lai CH, Cheng PY, Chen YY. Liver cirrhosis and risk ofintracerebral haemorrhage: a 9-year follow-up study. Stroke. 2011;42:2615–2617. doi:10.1161/STROKEAHA.111.617076
  • Mancuso A, Politi F, Maringhini A. Portal vein thromboses in cirrhosis: to treat or not to treat? Gastroenterology. 2018;154:758. doi:10.1053/j.gastro.2017.07.053
  • Piscaglia F, Sansone V. Reply to anticoagulation for portal vein thrombosis in cirrhosis. Am J Gastroenterol. 2019;114(6):1001–1002. doi:10.14309/ajg.0000000000000274
  • Chak EW. Anticoagulation of portal vein thrombosis in cirrhosis: first, do no harm. Am J Gastroenterol. 2019. doi:10.14309/ajg.0000000000000351
  • European Association for the Study of the Liver. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol. 2022;76(5):1151–1184. PMID: 35300861. doi:10.1016/j.jhep.2021.09.003
  • Hanafy AS, Abd-Elsalam S, Dawoud MM. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis. Vascul Pharmacol. 2019;113:86–91. PMID: 29886103. doi:10.1016/j.vph.2018.05.002
  • Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology. 2017;153:480–487. doi:10.1053/j.gastro.2017.04.042
  • Turon F, Hernández-Gea V, García-Pagán JC. Portal vein thrombosis: yes or no on anticoagulation therapy. Curr Opin Organ Transplant. 2018;23:250–256. doi:10.1097/MOT.0000000000000506
  • Piscaglia F, Benevento F, Pecorell A, Forgione A, Stefanescu H. Anticoagulation in cirrhotic portal vein thrombosis: no harm, but survival benefit still unclear. Am J Gastroenterol. 2020;115(1):145–146. PMID: 31809302. doi:10.14309/ajg.0000000000000483
  • Mahmoudi TM, Marquez V, Kayal A, Carvalho R, Weiss AA HCC complicated by PVT: outcome and the role of anticoagulation therapy. Can Liver J 2019;27:121–126. doi:10.3138/canlivj.2018-0026

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.